###begin article-title 0
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
Compound heterozygosity for a novel and a recurrent MFRP gene mutation in a family with the nanophthalmos-retinitis pigmentosa complex
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
To report a new familial case of the recently described autosomal recessive syndrome of nanophthalmos-retinitis pigmentosa-foveoschisis-optic disc drusen, which arises from compound heterozygosity for Membrane Frizzled-Related Protein (MFRP) mutations in a sibling pair of Mexican origin.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
Ophthalmological assessment included slit-lamp and dilated fundus examination, applanation tonometry, fundus photography, A-mode and B-mode ultrasound examination, electroretinogram, fluorescein retinal angiography, optical coherence tomography, and electrooculogram in both affected siblings. Molecular genetic analysis consisted of PCR amplification and direct automated sequence of the complete coding region of the MFRP gene. In addition, allele-specific cloning and sequencing techniques were used to characterize a heterozygous MFRP frameshift mutation.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 675 677 675 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</italic>
Clinical examination revealed high hyperopia of > +16 diopters while electroretinographic and fluorangiographic studies demonstrated a retinal dystrophy compatible with retinitis pigmentosa. Ultrasound examination showed nanophthalmos (eye axial length <15 mm) and optic disc drusen while optical coherence tomography evidenced cystoid macular edema. Nucleotide sequencing in DNA from both affected siblings disclosed the presence of two MFRP mutations: a novel heterozygous point mutation predicting a nonsense change from tyrosine (TAC) to a stop signal (TAA) at codon 317, and a heterozygous 1 bp deletion in exon 5, predicting a prematurely truncated protein (p.Asn167ThrfsX25).
###end p 6
###begin title 7
Discussion
###end title 7
###begin p 8
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
The third known family with the syndrome of nanophthalmos-retinitis pigmentosa-foveoschisis-optic disc drusen is presented. This is the first demonstration of compound heterozygosity for MFRP mutations as the source of the disease. The affected siblings described here are the youngest patients with the disease reported to date and the comparison of their clinical data with previous individuals with this syndrome suggest that some aspects of the phenotype are probably age-dependent.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 939 940 939 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 907 915 <span type="species:ncbi:9606">patients</span>
The complex of nanophthalmos-retinitis pigmentosa-foveoschisis-optic disc drusen is a distinct autosomal recessive entity recently identified in two unrelated families from Mexico and Spain [1,2]. The complex is caused by homozygous truncating mutations in Membrane Frizzled-Related Protein (MFRP), a gene located at chromosome 11q13 that encodes a membrane receptor protein highly expressed in retinal tissue which plays a potential role in the WNT pathway [3]. The two described families have distinct homozygous mutations, yet both have presented with a strikingly similar phenotype characteristically affecting structures located at the posterior pole of the eye [2]. Nanophthalmos, an anomaly in which eyes have a short axial length (13-18.5 mm), causes high hyperopia, typically ranging between +8.00 to +25.00 diopters [4]. Secondary glaucoma due to shallow anterior chamber is a frequent finding in patients with this condition [5-7].
###end p 10
###begin p 11
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
This syndrome has emerged as a novel form of syndromic retinitis pigmentosa with progressive photoreceptor dysfunction initiating typically at the second or third decade of life. Both familial cases currently known carry homozygous frameshift mutations at MFRP exon 5, predicting the introduction of premature stop codons [1,2]. Previously, MFRP mutations were identified in subjects with nanophthalmos and high hyperopia but without retinal dysfunction [8]. It is still not known why some MFRP mutations cause isolated nanophthalmos, while others trigger the nanophthalmos-retinitis pigmentosa-foveoschisis-optic disc drusen complex.
###end p 11
###begin p 12
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 270 282 <span type="species:ncbi:9606">participants</span>
In this work, we describe the clinical and genetic features of a new familial case of the syndrome of nanophthalmos-retinitis pigmentosa-foveoschisis-optic disc drusen in which two distinct MFRP mutations, including a novel nonsense change, were demonstrated. The study participants presented here are the youngest reported to date with the syndrome. Our study findings suggest that some aspects of the phenotype are probably age-dependant. This is the first demonstration of compound heterozygosity as the source of this unusual syndromic form of microphthalmos and retinitis pigmentosa.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Clinical studies: Two sibs were studied
###end title 14
###begin p 15
###xml 338 350 <span type="species:ncbi:9606">participants</span>
###xml 491 499 <span type="species:ncbi:9606">patients</span>
###xml 784 792 <span type="species:ncbi:9606">patients</span>
Ophthalmological examinations included best-corrected visual acuity (BCVA), slit-lamp and dilated fundus examination, applanation tonometry, fundus photography, A-mode and B-mode ultrasound examination (US), electroretinogram (ERG), fluorescein retinal angiography (FA), optical coherence tomography (OCT), and electrooculogram. Affected participants also underwent systemic evaluation (not only ocular examination, but also complete physical examination was performed) by a geneticist. The patients were recruited from the Department of Retina of our institution (Institute of Ophthalmology "Conde de Valenciana") and belonged to a Mexican Mestizo family from the central region of the country. No consanguinity was recorded among their parents, who had no vision abnormalities. The patients were the only two siblings from this marriage.
###end p 15
###begin title 16
Molecular genetic analyses
###end title 16
###begin p 17
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 975 979 975 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1014 1018 1014 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1209 1216 1205 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1285 1287 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 186 198 <span type="species:ncbi:9606">participants</span>
###xml 1209 1216 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
The two affected siblings participated in the study after providing informed consent. The study protocol was approved by the Institutional Review Board. Genomic DNA was obtained in both participants from peripheral blood lymphocytes according to standard methods [9]. The entire coding sequences and exon-intron boundaries of MFRP (located at 11q23, 13 exons) were amplified by PCR using pairs of primers derived from the normal published sequences (Ensembl sequence ENST00000261980). Primer sequences and annealing temperatures for PCR are shown in Table 1. Direct sequencing of PCR amplified products was performed using the Big Dye Terminator Cycle Sequencing kit (Applied Biosystems, Foster City, CA), with about 10 ng of template DNA added to each reaction. Samples were run in an ABI Prism 310 Genetic Analyzer (Applied Biosystems). Sequences were compared manually. Additionally, an allele-specific cloning and sequencing approach was used to precisely characterize a MFRP frameshift mutation. Briefly, new MFRP exon 5 products were amplified from genomic DNA, gel-purified, ligated by means of a TA-ligation method into the TA-cloning vector pGEM-T (Promega, Madison, WI), and subcloned into DH5alpha E. coli competent cells (Invitrogen, Carlsbad, CA) as previously described [10]. The plasmid inserts were sequenced by following the aforedescribed protocol and by using the forward pUC/M13 primer.
###end p 17
###begin title 18
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
PCR primers for MFRP gene amplification
###end title 18
###begin title 19
Results
###end title 19
###begin title 20
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient #1
###end title 20
###begin p 21
###xml 569 578 569 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 721 730 721 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 15 19 <span type="species:ncbi:9606">girl</span>
###xml 21 28 <span type="species:ncbi:9606">patient</span>
###xml 233 240 <span type="species:ncbi:9606">patient</span>
An 18-year-old girl, patient #1 had a BCVA of 20/200 and refractive error of +16.75 OU. In both eyes, her intraocular pressure was 12 mmHg, normal horizontal corneal diameters (11.5 mm), and no anterior chamber angle anomalies. This patient had progressive nyctalopia and decreasing visual acuity since infancy. Funduscopic examination disclosed very small optic cups (<20%), cystic lesions on macular areas, diminished foveal reflex in both eyes, and retinal pigmented epithelium (RPE) mottling and atrophy mainly at posterior pole and peripheral retina in both eyes (Figure 1A). There was no clinical evidence of retinoschisis. FA showed transmission defects corresponding to the observed mottled areas of RPE atrophy (Figure 1B). ERG showed abolished scotopic light response in both eyes while photopic response was recordable but subnormal OU. The Arden ratio was 144% OD and 108% OS (normal values: 180%-200%). Ultrasonographic examination demonstrated eye axial length of 14.79 mm (OD) and 14.65 mm (OS), but it showed optic nerve drusen and thickened choroid in both eyes. OCT imaging revealed increased foveal thickness that was 331 mum OD and 317 mum OS. OCT also showed hyporeflective images of cystic appearance, and splitting of inner retinal layers.
###end p 21
###begin p 22
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 222 223 222 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 373 374 373 374 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 104 111 <span type="species:ncbi:9606">patient</span>
###xml 349 356 <span type="species:ncbi:9606">patient</span>
###xml 518 525 <span type="species:ncbi:9606">patient</span>
Eye phenotype in Retinitis pigmentosa-nanophthalmos complex. A: Fundus photograph of the right eye from patient #1 reveals optic disc drusen, diffuse retinal pigment epithelium atrophy, and blunting of the macular reflex. B: Fluorescein angiography shows choroidal transmission hyperfluorescence corresponding to retinal pigment epithelium atrophy (patient #1, right eye). C: OCT image demonstrates cystoid macular edema, inner retinal layers splitting with discrete bridging elements at the fovea, and macular cysts (patient #2, left eye).
###end p 22
###begin title 23
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient #2
###end title 23
###begin p 24
###xml 1143 1152 1141 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
###xml 27 34 <span type="species:ncbi:9606">patient</span>
###xml 39 46 <span type="species:ncbi:9606">patient</span>
###xml 297 304 <span type="species:ncbi:9606">patient</span>
###xml 971 978 <span type="species:ncbi:9606">patient</span>
The 16 year-old brother of patient #1, patient #2 presented with a BCVA of 20/200 OD and 20/100 OS. In both eyes, he had a refractive error of +16.75 OU, intraocular pressure of 12 mmHg, normal horizontal corneal diameters (11.5 mm), and no anterior chamber angle anomalies. Like his sister, this patient had progressive nyctalopia and decreasing visual acuity since infancy. He had also cystic lesions on macular areas, diminished foveal reflexes, and RPE mottling and atrophy mainly at posterior pole and peripheral retina in both eyes. Also in both eyes, he had cystic lesions on macular area, diminished foveal reflex, and RPE mottling and atrophy mainly at posterior pole and peripheral retina. There was no clinical evidence of retinoschisis. FA showed diffuse transmission defects corresponding to the observed areas of RPE mottling and atrophy. ERG demonstrated a subnormal scotopic light response in OD and an abolished response in OS. OCT imaging revealed this patient had increased foveal thickness of 399 mum OD and 409 mum OS, as well as hyporeflective images of cystic appearance, and apparent splitting of inner retinal layers (Figure 1C). The Arden ratio was 122% OD and 116% OS. Ultrasonography revealed his eye axial length was 14.93 mm OD, and 14.67 mm OS. He had optic nerve drusen and thickened choroids in both eyes.
###end p 24
###begin title 25
Molecular genetic findings
###end title 25
###begin p 26
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 153 164 153 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A,B</xref>
###xml 222 224 222 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</italic>
###xml 374 383 374 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
Nucleotide sequence in DNA from both affected siblings disclosed the presence of two MFRP mutations: a heterozygous 1-bp deletion (c.498delC) in exon 5 (Figure 2A,B), predicting a prematurely truncated protein (p.Asn167ThrfsX25); and a heterozygous point mutation from C to A, predicting a nonsense change from Tyrosine (TAC) to a stop signal (TAA), at codon 317 in exon 8 (Figure 2C). This nonsense mutation has not been previously described while the c.498delC mutation was recently identified by Crespi et al. [2] in a familial case in Spain of the nanophthalmos-retinitis pigmentosa syndrome.
###end p 26
###begin p 27
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 245 247 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</italic>
###xml 313 314 313 314 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 364 365 364 365 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 126 133 <span type="species:ncbi:9606">patient</span>
MFRP gene mutations in Retinitis pigmentosa-nanophthalmos complex. A: Partial nucleotidic sequence of MFRP exon 5 in DNA from patient # 1 shows a heterozygous 1 bp deletion (c.498delC), which predicts a prematurely truncated protein (p.Asn167ThrfsX25). Compare this illustration with the normal sequence shown in B in which arrow points to the deleted nucleotide. C: Partial DNA sequence of MFRP exon 8 shows a heterozygous point mutation from C to A (arrow), predicting a nonsense change from tyrosine (TAC) to a stop signal (TAA), at codon 317.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
Nanophthalmos is an ocular anomaly characterized by the combination of microphthalmos, microcornea, and a tendency toward spontaneous or postsurgical uveal effusions [11,12]. Nanophthalmos is sometimes referred to as "simple microphthalmos" [13,14]. The short distance between the lens and retina in nanophthalmic eyes causes extreme hyperopia with refractive defects ranging between +8.00 to +25.00 diopters. Typically, nanophthalmic eyes have an axial length of 13-18.5 mm and are associated with a shallow anterior chamber and thickening of both the choroidal vascular bed and sclera [15-17].
###end p 29
###begin p 30
###xml 31 32 31 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mfrp</italic>
###xml 412 415 412 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd6</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 276 281 <span type="species:ncbi:9606">human</span>
###xml 385 390 <span type="species:ncbi:10090">mouse</span>
In 2006, Ayala-Ramirez et al. [1] described the ophthalmologic features of a Mexican family in whom four siblings were affected by a novel autosomal recessive eye disease characterized by posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen. As human MFRP mutations result in nanophthalmos and mutations in the orthologous Mfrp gene causes the recessive mouse retinal degeneration rd6, these authors searched for MFRP mutations as a source for this novel phenotype. A homozygous frameshift P166fsX199 mutation in MFRP segregated with the disease in that pedigree, validating mutations at this gene as the responsible for the phenotype [1].
###end p 30
###begin p 31
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 36 44 <span type="species:ncbi:9606">patients</span>
###xml 371 376 <span type="species:ncbi:10090">mouse</span>
The panocular phenotype observed in patients with the nanophthalmos-retinitis pigmentosa complex (microphthalmia, retinitis pigmentosa, foveoschisis, and optic disc drusen) suggests that MFRP plays a wide role in eye development, functioning both as a regulator of axial eye length and as a critical molecule for photoreceptor function. Recent studies in the Mfrprd6/rd6 mouse model indicate that MFRP is necessary for photoreceptor maintenance [18].
###end p 31
###begin p 32
###xml 598 601 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd6</italic>
###xml 719 722 719 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd6</italic>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1052 1056 1052 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
###xml 450 458 <span type="species:ncbi:9606">patients</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1075 1079 <span type="species:ncbi:10090">mice</span>
###xml 1084 1090 <span type="species:ncbi:9606">humans</span>
The affected siblings presented in this work are the youngest described to date. Several clinical features are important to note. Fundus examination in both patients revealed multiple, irregular, round yellow-white flecks, mainly located at the posterior pole retina and did not demonstrate the presence of "bone spicule" hyperpigmentation. The absence of this hyperpigmentation is significant because previous reports documented its presence in all patients (seven from two unrelated families) with nanophthalmos-retinitis pigmentosa complex. This is an interesting finding as mice homozygous for rd6 have small, evenly spaced white dots throughout their retinas that become apparent by eight weeks of age. Homozygous rd6 mice begin to show clinical signs of retinal degeneration at seven months of age. By 15 months, the fundus has developed a mildly pigmented granular and mottled appearance; individual spots can still be seen, although less frequently, in mice up to about two years old [19]. These data, along with our observations, suggest that MFRP mutations in both mice and humans lead to a fundus phenotype characteristic of "typical" retinitis pigmentosa, with retinal pigmentary changes occurring in the form of fine mottling or granularity with surrounding areas of atrophy in the earlier stages followed by the typical "bone-spicule" pattern of hyperpigmentation in midperipheral retina, at later stages.
###end p 32
###begin p 33
###xml 43 44 43 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 1149 1151 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1385 1386 1385 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 1474 1475 1474 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 5 16 <span type="species:ncbi:9606">participant</span>
###xml 192 200 <span type="species:ncbi:9606">patients</span>
###xml 1139 1147 <span type="species:ncbi:9606">patients</span>
###xml 1325 1333 <span type="species:ncbi:9606">patients</span>
###xml 1417 1429 <span type="species:ncbi:9606">participants</span>
Each participant from the original family [1] exhibited localized foveal schisis with no clinical, fluorangiographic, or OCT evidence of cystoid macular edema or macular cysts. Retinal OCT in patients from the family described by Crespi et al. [2] and in the young siblings we describe here showed foveal cystic lesions reminiscent of cystoid macular edema. There was, however, schisis of external retinal layers evident in the present study's siblings, suggesting the occurrence of two independent maculopathies: foveoschisis and cystoid macular edema. Although this finding suggests that it is probable that macular cysts leads to foveoschisis, it is also likely that the combined effect of both nanophthalmos and macular cysts could account for the localized foveal schisis characteristic of this syndromic form of retinitis pigmentosa. It is also possible that foveoschisis is a permanent sequela after cystoid edema resolves in nanophthalmic eyes, contrary to that which occurs in normal sized eyes. Cystoid macular edema is a frequent finding in retinitis pigmentosa and, according to OCT results, seems to occur in 32%-49% of these patients [20,21]. Glaucoma is another finding that suggests there is an age-dependent component to nanophthalmos-retinitis pigmentosa complex. While not observed in young or middle-aged patients in this study and the one by Ayala-Ramirez et al. [1], glaucoma was noted in older participants in the research performed by Crespi et al. [2]. Further study of additional subjects of a range of ages with this complex would help to clarify these issues.
###end p 33
###begin p 34
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
Finally, this case of MFRP compound heterozygosity suggests that the disorder, or at least the carrier status, could be more frequent than previously thought. We propose to suspect the diagnosis of this complex diseases in those patients with retinitis pigmentosa who also exhibit high refractive errors ranging between +8.00 to +25 diopters.
###end p 34
###begin title 35
Acknowledgments
###end title 35
###begin p 36
We thank Dr. Raul Ayala-Ramirez for critical assessment of the retinal phenotype and for reading the manuscript. This work was partially supported by CONACYT grant 071110.
###end p 36
###begin title 37
References
###end title 37
###begin article-title 38
A new autosomal recessive syndrome consisting of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen is caused by a MFRP gene mutation.
###end article-title 38
###begin article-title 39
A novel mutation confirms MFRP as the gene causing the syndrome of nanophthalmos-renititis pigmentosa-foveoschisis-optic disk drusen.
###end article-title 39
###begin article-title 40
Molecular cloning and characterization of MFRP, a novel gene encoding a membrane-type Frizzled-related protein.
###end article-title 40
###begin article-title 41
Hereditary high hypermetropia in the Faroe Islands.
###end article-title 41
###begin article-title 42
Ocular dimensions in the heredity of angle closure glaucoma.
###end article-title 42
###begin article-title 43
Angle-closure glaucoma in nanophthalmos.
###end article-title 43
###begin article-title 44
Retinal degeneration with nanophthalmos, cystic macular degeneration, and angle closure glaucoma. A new recessive syndrome.
###end article-title 44
###begin article-title 45
Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein.
###end article-title 45
###begin article-title 46
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells.
###end article-title 46
###begin article-title 47
###xml 42 50 <span type="species:ncbi:9606">patients</span>
PAX6 gene intragenic deletions in Mexican patients with congenital aniridia.
###end article-title 47
###begin article-title 48
Familial nanophthalmos.
###end article-title 48
###begin article-title 49
Nanophthalmos with uveal effusion: clinical and embryologic considerations.
###end article-title 49
###begin article-title 50
Autosomal dominant simple microphthalmos.
###end article-title 50
###begin article-title 51
Autosomal dominant nanophthalmos (NNO1) with high hyperopia and angle-Closure glaucoma maps to chromosome 11.
###end article-title 51
###begin article-title 52
Nanophthalmic sclera. Fibronectin studies.
###end article-title 52
###begin article-title 53
Retinitis pigmentosa, nanophthalmos, and optic disc drusen: a case report.
###end article-title 53
###begin article-title 54
Posterior microphthalmos versus nanophthalmos.
###end article-title 54
###begin article-title 55
Membrane frizzled-related protein is necessary for the normal development and maintenance of photoreceptor outer segments.
###end article-title 55
###begin article-title 56
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6.
###end article-title 56
###begin article-title 57
Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial.
###end article-title 57
###begin article-title 58
###xml 97 105 <span type="species:ncbi:9606">patients</span>
The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination.
###end article-title 58

